摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(6S,7S)-6-{[4-(4-cyanophenyl)piperazin-1-yl]carbonyl}-N-hydroxy-5-azaspiro[2.5]octane-7-carboxamide | 791827-17-3

中文名称
——
中文别名
——
英文名称
(6S,7S)-6-{[4-(4-cyanophenyl)piperazin-1-yl]carbonyl}-N-hydroxy-5-azaspiro[2.5]octane-7-carboxamide
英文别名
(6S,7S)-6-[4-(4-cyanophenyl)piperazine-1-carbonyl]-N-hydroxy-5-azaspiro[2.5]octane-7-carboxamide
(6S,7S)-6-{[4-(4-cyanophenyl)piperazin-1-yl]carbonyl}-N-hydroxy-5-azaspiro[2.5]octane-7-carboxamide化学式
CAS
791827-17-3
化学式
C20H25N5O3
mdl
——
分子量
383.45
InChiKey
IFVHOCNRWKSWKO-IRXDYDNUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    28
  • 可旋转键数:
    3
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    109
  • 氢给体数:
    3
  • 氢受体数:
    6

文献信息

  • Aza spiro alkane derivatives as inhibitors of metalloproteases
    申请人:——
    公开号:US20040259896A1
    公开(公告)日:2004-12-23
    The present invention provides a compound of Formula I or Formula II: 1 enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
    本发明提供了公式I或公式II的化合物:1对映异构体,对映体,前药,溶剂化物,代谢物或其药学上可接受的盐,其中组分变量在此处提供。公式I和II的化合物是蛋白酶调节剂,可用于治疗与蛋白酶活性相关的疾病,如关节炎,癌症,心血管疾病,皮肤疾病,炎症和过敏症。
  • AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES
    申请人:Yao Wenqing
    公开号:US20090124649A1
    公开(公告)日:2009-05-14
    The present invention provides a compound of Formula I or Formula II: enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
    本发明提供了I式或II式的化合物:其对映异构体、顺反异构体、前药、溶剂化物、代谢物或其药学上可接受的盐,其中所述的组分变量已在此处提供。I和II式的化合物是蛋白酶的调节剂,并且在治疗与蛋白酶活性相关的疾病,例如关节炎、癌症、心血管疾病、皮肤疾病、炎症和过敏症方面很有用。
  • AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLOPROTEASES
    申请人:Yao Wenqing
    公开号:US20110288068A1
    公开(公告)日:2011-11-24
    The present invention provides a compound of Formula I or Formula II: enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
    本发明提供了化合物I或化合物II的化合物:对映体、顺反异构体、前药、溶剂化物、代谢物或其药学上可接受的盐,其中组成变量在此处提供。化合物I和II是蛋白酶调节剂,可用于治疗与蛋白酶活性相关的疾病,如关节炎、癌症、心血管疾病、皮肤疾病、炎症和过敏症。
  • AZA Spiro Alkane Derivatives as Inhibitors of Metalloproteases
    申请人:INCYTE CORPORATION
    公开号:US20140187530A1
    公开(公告)日:2014-07-03
    The present invention provides a compound of Formula I or Formula II: enantiomer, diastereomer, prodrug, solvate, metabolite, or pharmaceutically acceptable salt thereof, wherein constituent variables are provided herein. The compounds of Formula I and II are modulators of metalloproteases and are useful in treating diseases associated with metalloprotease activity such as arthritis, cancer, cardiovascular disorders, skin disorders, inflammation and allergic conditions.
    本发明提供公式I或公式II的化合物:其对映体,顺反异构体,前药,溶剂化物,代谢物或其药学上可接受的盐,其中组成变量在此提供。公式I和II的化合物是蛋白酶调节剂,并且在治疗与蛋白酶活性相关的疾病,例如关节炎,癌症,心血管疾病,皮肤疾病,炎症和过敏症方面是有用的。
  • AZA SPIRO ALKANE DERIVATIVES AS INHIBITORS OF METALLPROTEASES
    申请人:Incyte Corporation
    公开号:EP1622569B1
    公开(公告)日:2015-12-02
查看更多